Cimon Medical

About:

Cimon Medical develops and manufactures novel Doppler ultrasound technology for continuous and direct monitoring of blood-flow

Website: https://cimonmedical.com/

Top Investors: Farvatn Venture, Investinor, ProVenture, CoFounder

Description:

Cimon Medical is the owner of a unique proprietary technology for continuous monitoring of blood-flow using non-invasive Doppler ultrasound. The core of the innovation is a coin-sized ultrasound probe constructed as a single element transducer with an unfocused beam that can measure blood circulation continuously by illuminating a 1×4 cm cylindric area of the tissue and capture all blood flow signals in this volume simultaneously. From clinical research using this equipment, it has become clear that relative measures of blood volume flow within a region can be obtained with much simpler equipment than an absolute measure but be just as valuable. This circumvents the problem that has stumped previous attempts at continuous blood flow monitoring: attempting to establish an absolute measure in a single blood vessel. This means that there is no need for expensive transducers, complex processing systems, or skilled operators.

Total Funding Amount:

64.5M NOK

Headquarters Location:

Trondheim, Sor-Trondelag, Norway

Founded Date:

2020-06-20

Contact Email:

contact(AT)cimonmecical.com

Founders:

Hans Torp, Siri Ann Nyrnes, Tormod Thomsen

Number of Employees:

1-10

Last Funding Date:

2020-12-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai